{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:23:35Z","timestamp":1788780215621,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,1,20]],"date-time":"2012-01-20T00:00:00Z","timestamp":1327017600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s10585-011-9446-0","type":"journal-article","created":{"date-parts":[[2012,1,19]],"date-time":"2012-01-19T07:46:48Z","timestamp":1326959208000},"page":"239-252","source":"Crossref","is-referenced-by-count":52,"title":["The anti-adhesive mucin podocalyxin may help initiate the transperitoneal metastasis of high grade serous ovarian carcinoma"],"prefix":"10.1007","volume":"29","author":[{"given":"Jane A.","family":"Cipollone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia L.","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"K\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E.","family":"Kalloger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tak","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Blake","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"McNagny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin D.","family":"Roskelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,20]]},"reference":[{"key":"9446_CR1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.54.1.8","volume":"54","author":"A Jemal","year":"2004","unstructured":"Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ, American Cancer Society (2004) Cancer statistics. CA Cancer J Clin 54:8\u201329","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"9446_CR2","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1525-1438.2007.00667.x","volume":"17","author":"EL Trimble","year":"2007","unstructured":"Trimble EL, Davis J, Disaia P, Fujiwara K, Gaffney D, Kristensen G, Ledermann J, Pfisterer J, Quinn M, Reed N, Schoenfeldt M, Thigpen JT, Gynecologic Cancer Intergroup (2007) Clinical trials in gynecological cancer. Int J Gynecol Cancer 17(3):547\u2013556","journal-title":"Int J Gynecol Cancer"},{"key":"9446_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0028-2243(88)80010-8","volume":"27","author":"F Flam","year":"1988","unstructured":"Flam F, Einhorn N, Sjovall K (1988) Symptomatology of ovarian cancer. Eur J Obstet Gynecol Reprod Biol 27:53\u201357","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"9446_CR4","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0272-2712(03)00058-1","volume":"23","author":"B Davidson","year":"2003","unstructured":"Davidson B, Risberg B, Reich R, Berner A (2003) Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis. Clin Lab Med 23:729\u2013754","journal-title":"Clin Lab Med"},{"issue":"2","key":"9446_CR5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0006-291X(02)02844-9","volume":"300","author":"WM Schopperle","year":"2003","unstructured":"Schopperle WM, Kershaw DB, DeWolf WC (2003) Human embryonal carcinoma tumor antigen, Gp200\/GCTM-2, is podocalyxin. Biochem Biophys Res Commun 300(2):285\u2013290","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"9446_CR6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1309\/7BHLAHHU0N4MHT7Q","volume":"124","author":"TW Kelley","year":"2005","unstructured":"Kelley TW, Huntsman D, McNagny KM, Roskelley CD, Hsi ED (2005) Podocalyxin: a marker of blasts in acute leukemia. Am J Clin Pathol 124(1):134\u2013142","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"9446_CR7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.humpath.2006.08.025","volume":"38","author":"JT Ney","year":"2007","unstructured":"Ney JT, Zhou H, Sipos B, Buttner R, Chen X, Kloppel G, Gutgemann I (2007) Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts. Hum Pathol 38(2):359\u2013364","journal-title":"Hum Pathol"},{"issue":"3","key":"9446_CR8","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1634\/stemcells.2005-0597","volume":"25","author":"WM Schopperle","year":"2007","unstructured":"Schopperle WM, DeWolf WC (2007) The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells 25(3):723\u2013730","journal-title":"Stem Cells"},{"issue":"11","key":"9446_CR9","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1136\/jcp.2008.059956","volume":"61","author":"H Yasuoka","year":"2008","unstructured":"Yasuoka H, Tsujimoto M, Hirokawa M, Tori M, Nakahara M, Miyauchi A, Kodama R, Sanke T, Nakamura Y (2008) Podocalyxin expression in undifferentiated thyroid carcinomas. J Clin Pathol 61(11):1228\u20131229","journal-title":"J Clin Pathol"},{"issue":"3","key":"9446_CR10","doi-asserted-by":"crossref","first-page":"C505","DOI":"10.1152\/ajpcell.00472.2008","volume":"296","author":"SN Thomas","year":"2009","unstructured":"Thomas SN, Schnaar RL, Konstantopoulos K (2009) Podocalyxin-like protein is an E-\/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells. Am J Physiol Cell Physiol 296(3):C505\u2013C513","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"9446_CR11","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.2353\/ajpath.2010.090539","volume":"176","author":"YH Hsu","year":"2010","unstructured":"Hsu YH, Lin WL, Hou YT, Pu YS, Shun CT, Chen CL, Wu YY, Chen JY, Chen TH, Jou TS (2010) Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7. Am J Pathol 176(6):3050\u20133061","journal-title":"Am J Pathol"},{"issue":"5","key":"9446_CR12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/hmg\/ddi487","volume":"15","author":"G Casey","year":"2006","unstructured":"Casey G, Neville PJ, Liu X, Plummer SJ, Cicek MS, Krumroy LM, Curran AP, McGreevy MR, Catalona WJ, Klein EA, Witte JS (2006) Podocalyxin variants and risk of prostate cancer and tumor aggressiveness. Hum Mol Genet 15(5):735\u2013741","journal-title":"Hum Mol Genet"},{"issue":"15","key":"9446_CR13","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1158\/0008-5472.CAN-04-0240","volume":"64","author":"A Somasiri","year":"2004","unstructured":"Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM, Roskelley CD (2004) Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res 64(15):5068\u20135073","journal-title":"Cancer Res"},{"issue":"31","key":"9446_CR14","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1038\/onc.2011.60","volume":"30","author":"H-H Cheung","year":"2011","unstructured":"Cheung H-H, Davis AJ, Lee T-L, Pang AL, Nagrani S, Rennert OM, Chan W-Y (2011) Methylation of an intronic region regulates miR-199a in testicular tumor malignancy. Oncogene 30(31):3404\u20133415","journal-title":"Oncogene"},{"key":"9446_CR15","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1083\/jcb.98.4.1591","volume":"98","author":"D Kerjaschki","year":"1984","unstructured":"Kerjaschki D, Sharkey DJ, Farquhar MG (1984) Identification and characterization of podocalyxin-the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol 98:1591\u20131596","journal-title":"J Cell Biol"},{"issue":"4","key":"9446_CR16","first-page":"913","volume":"137","author":"G Dekan","year":"1990","unstructured":"Dekan G, Miettinen A, Schnabel E, Farquhar MG (1990) Binding of monoclonal antibodies to glomerular endothelium, slit membranes, and epithelium after in vivo injection. Localization of antigens and bound IgGs by immunoelectron microscopy. Am J Pathol 137(4):913\u2013927","journal-title":"Am J Pathol"},{"key":"9446_CR17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1084\/jem.194.1.13","volume":"194","author":"R Doyonnas","year":"2001","unstructured":"Doyonnas R, Kershaw DB, Duhme C, Merkens H, Chelliah S, Graf T, McNagny KM (2001) Anuria, omphalocele, and perinatal lethality in mice lacking the CD-34-related protein podocalyxin. J Exp Med 194:13\u201327","journal-title":"J Exp Med"},{"issue":"3","key":"9446_CR18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0002-9440(10)65328-X","volume":"154","author":"A Miettinen","year":"1999","unstructured":"Miettinen A, Solin ML, Reivinen J, Juvonen E, Vaisanen R, Holthofer H (1999) Podocalyxin in rat platelets and megakaryocytes. Am J Pathol 154(3):813\u2013822","journal-title":"Am J Pathol"},{"issue":"3","key":"9446_CR19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.modgep.2004.10.002","volume":"5","author":"N Vitureira","year":"2005","unstructured":"Vitureira N, McNagny K, Soriano E, Burgaya F (2005) Pattern of expression of the podocalyxin gene in the mouse brain during development. Gene Expr Patterns 5(3):349\u2013354","journal-title":"Gene Expr Patterns"},{"issue":"2","key":"9446_CR20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1083\/jcb.200407072","volume":"168","author":"D Meder","year":"2005","unstructured":"Meder D, Shevchenko A, Simons K, F\u00fcllekrug J (2005) Gp135\/podocalyxin and NHERF-2 participate in the formation of a preapical domain during polarization of MDCK cells. J Cell Biol 168(2):303\u2013313","journal-title":"J Cell Biol"},{"key":"9446_CR21","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pone.0000237","volume":"2","author":"JS Nielsen","year":"2007","unstructured":"Nielsen JS, McCoy M, Chelliah S, Vogl AW, Roskelley CD, McNagny KM (2007) The CD34-related molecule podocalyxin is a potent inducer of microvillus formation. PLoS ONE 2:e237","journal-title":"PLoS ONE"},{"issue":"4","key":"9446_CR22","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.devcel.2009.08.011","volume":"17","author":"B Strilic","year":"2009","unstructured":"Strilic B, Kucera T, Eglinger J, Hughes MR, McNagny KM, Tsukita S, Dejana E, Ferrara Lammert E (2009) The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell 17(4):505\u2013515","journal-title":"Dev Cell"},{"issue":"2","key":"9446_CR23","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/er.22.2.255","volume":"22","author":"N Auersperg","year":"2001","unstructured":"Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC (2001) Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 22(2):255\u2013288","journal-title":"Endocr Rev"},{"issue":"3","key":"9446_CR24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, Shih IeM (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34(3):433\u2013443","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"9446_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","volume":"27","author":"E Jarboe","year":"2008","unstructured":"Jarboe E, Folkins A, Nucci MR, Kindelberger D, Drapkin R, Miron A, Lee Y, Crum CP (2008) Serous carcinogenesis in the fallopian tube: a descriptive classification. Int J Gynecol Pathol 27(1):1\u20139","journal-title":"Int J Gynecol Pathol"},{"issue":"25","key":"9446_CR26","doi-asserted-by":"crossref","first-page":"15708","DOI":"10.1074\/jbc.272.25.15708","volume":"272","author":"DB Kershaw","year":"1997","unstructured":"Kershaw DB, Beck SG, Wharram BL, Wiggins JE, Goyal M, Thomas PE, Wiggins RC (1997) Molecular cloning and characterization of human podocalyxin-like protein. J Biol Chem 272(25):15708\u201315714","journal-title":"J Biol Chem"},{"issue":"8","key":"9446_CR27","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.humpath.2008.01.003","volume":"39","author":"CB Gilks","year":"2008","unstructured":"Gilks CB, Ionescu DN, Kalloger SE, K\u00f6bel M, Irving J, Clarke B, Santos J, Le N, Moravan V, Swenerton K, Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency (2008) Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Hum Pathol 39(8):1239\u20131251","journal-title":"Hum Pathol"},{"issue":"12","key":"9446_CR28","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","volume":"5","author":"M K\u00f6bel","year":"2008","unstructured":"K\u00f6bel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, Prentice LM, Miller D, Santos J, Swenerton K, Gilks CB, Huntsman D (2008) Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 5(12):e232","journal-title":"PLoS Med"},{"issue":"9","key":"9446_CR29","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.febslet.2007.03.072","volume":"581","author":"ML Graves","year":"2007","unstructured":"Graves ML, Zhou L, MacDonald G, Mueller CR, Roskelley CD (2007) Regulation of the BRCA1 promoter in ovarian surface epithelial cells and ovarian carcinoma cells. FEBS Lett 581(9):1825\u20131833","journal-title":"FEBS Lett"},{"issue":"1","key":"9446_CR30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0092-8674(83)90155-1","volume":"34","author":"ND Connell","year":"1983","unstructured":"Connell ND, Rheinwald JG (1983) Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 34(1):245\u2013253","journal-title":"Cell"},{"key":"9446_CR31","first-page":"4781","volume":"62","author":"J Pinkas","year":"2002","unstructured":"Pinkas J, Leder P (2002) Mek1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of epithelial to mesenchymal transition. Cancer Res 62:4781\u20134790","journal-title":"Cancer Res"},{"issue":"11","key":"9446_CR32","first-page":"5379","volume":"43","author":"TC Hamilton","year":"1983","unstructured":"Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR, Ozols RF (1983) Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res 43(11):5379\u20135389","journal-title":"Cancer Res"},{"key":"9446_CR33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/gyno.1995.1214","volume":"58","author":"SA Cannistra","year":"1995","unstructured":"Cannistra SA, Ottensmeier C, Niloff J, Orta B, DiCarlo J (1995) Expression and function of \u03b21 and \u03b1v\u03b23 integrins in ovarian cancer. Gynecol Oncol 58:216\u2013225","journal-title":"Gynecol Oncol"},{"key":"9446_CR34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1083\/jcb.200209105","volume":"160","author":"S Rangarajan","year":"2003","unstructured":"Rangarajan S, Enserink JM, Kuiperij HB, de Rooij J, Price LS, Schwede F, Bos JL (2003) Cyclic AMP induces integrin-mediated adhesion through Epac and Rap1 upon stimulation of the \u03b22-adrenergic receptor. J Cell Biol 160:487\u2013493","journal-title":"J Cell Biol"},{"key":"9446_CR35","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1091\/mbc.11.9.3219","volume":"11","author":"T Takeda","year":"2000","unstructured":"Takeda T, Go WY, Orlando RA, Farquhar MG (2000) Expression of podocalyxin inhibits cell\u2013cell adhesion and modifies junctional properties in madin-Darby Canine Kidney Cells. Mol Biol Cell 11:3219\u20133232","journal-title":"Mol Biol Cell"},{"key":"9446_CR36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1128\/IAI.60.1.56-62.1992","volume":"60","author":"KM Abdullah","year":"1992","unstructured":"Abdullah KM, Udoh EA, Shewen PE, Mellors A (1992) A neutral glycoprotease of Pasteurella haemolytica A1 specifically cleaves O-sialoglycoproteins. Infect Immun 60:56\u201362","journal-title":"Infect Immun"},{"issue":"1","key":"9446_CR37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ygyno.2003.12.034","volume":"93","author":"KM Burleson","year":"2004","unstructured":"Burleson KM, Casey RC, Skubitz KM, Pambuccian SE, Oegema TR Jr, Skubitz AP (2004) Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol Oncol 93(1):170\u2013181","journal-title":"Gynecol Oncol"},{"issue":"1","key":"9446_CR38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","volume":"19","author":"CP Crum","year":"2007","unstructured":"Crum CP, Drapkin R, Miron A, Ince TA, Muto M, Kindelberger DW, Lee Y (2007) The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 19(1):3\u20139","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"25","key":"9446_CR39","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","volume":"25","author":"MJ Callahan","year":"2007","unstructured":"Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, Feltmate CM, Berkowitz RS, Muto MG (2007) Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 25(25):3985\u20133990","journal-title":"J Clin Oncol"},{"issue":"2, Suppl 1","key":"9446_CR40","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.ygyno.2006.08.022","volume":"103","author":"J Fountain","year":"2006","unstructured":"Fountain J, Trimble E, Birrer MJ (2006) Summary and discussion of session recommendations. Gynecol Oncol 103(2, Suppl 1):S23\u2013S25","journal-title":"Gynecol Oncol"},{"key":"9446_CR41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1083\/jcb.201009001","volume":"193","author":"SS Francis","year":"2011","unstructured":"Francis SS, Sfakianos J, Lo B, Mellman I (2011) A hierarchy of signals regulates entry of membrane proteins into the ciliary membrane domain in epithelial cells. J Cell Biol 193:219\u2013233","journal-title":"J Cell Biol"},{"key":"9446_CR42","doi-asserted-by":"crossref","first-page":"F1129","DOI":"10.1152\/ajprenal.00131.2001","volume":"282","author":"Y Li","year":"2002","unstructured":"Li Y, Li J, Straight SW, Kershaw DB (2002) PDZ domain-mediated interaction of rabbit podocalyxin and Na(+)\/H(+) exchange regulatory factor-2. Am J Physiol Renal Physiol 282:F1129\u2013F1139","journal-title":"Am J Physiol Renal Physiol"},{"key":"9446_CR43","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1634\/stemcells.2005-0426","volume":"24","author":"PC Tan","year":"2006","unstructured":"Tan PC, Furness SG, Merkens H, Lin S, McCoy ML, Roskelley CD, Kast J, McNagny KM (2006) Na+\/H+ exchanger regulatory factor-1 is a hematopoietic ligand for a subset of the CD34 family of stem cell surface proteins. Stem Cells 24:1150\u20131161","journal-title":"Stem Cells"},{"key":"9446_CR44","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1681\/ASN.V1281589","volume":"12","author":"RA Orlando","year":"2001","unstructured":"Orlando RA, Takeda T, Zak B, Schmieder S, Benoit VM, McQuistan T, Furthmayr H, Farquhar MG (2001) The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin. J Am Soc Nephrol 12:1589\u20131598","journal-title":"J Am Soc Nephrol"},{"key":"9446_CR45","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1172\/JCI12539","volume":"108","author":"T Takeda","year":"2001","unstructured":"Takeda T, McQuistran T, Orlando RA, Farquhar MG (2001) Loss of glomerular foot processes is associated with uncoupling of podocalyxin from the actin cytoskeleton. J Clin Invest 108:289\u2013301","journal-title":"J Clin Invest"},{"issue":"13","key":"9446_CR46","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1158\/0008-5472.CAN-06-3575","volume":"67","author":"S Sizemore","year":"2007","unstructured":"Sizemore S, Cicek M, Sizemore N, Ng KP, Casey G (2007) Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin. Cancer Res 67(13):6183\u20136191","journal-title":"Cancer Res"},{"issue":"4","key":"9446_CR47","doi-asserted-by":"crossref","first-page":"e18715","DOI":"10.1371\/journal.pone.0018715","volume":"6","author":"X Meng","year":"2011","unstructured":"Meng X, Ezzati P, Wilkins JA (2011) Requirement of podocalyxin in TGF-beta induced epithelial mesenchymal transition. PLoS ONE 6(4):e18715","journal-title":"PLoS ONE"},{"issue":"2","key":"9446_CR48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.pgp.0000185410.39050.ac","volume":"25","author":"M Kobel","year":"2006","unstructured":"Kobel M, Gradhand E, Zeng K, Schmitt WD, Kriese K, Lantzsch T, Wolters M, Dittmer J, Strauss HG, Thomssen C, Hauptmann S (2006) Ezrin promotes ovarian carcinoma cell invasion and its retained expression predicts poor prognosis in ovarian carcinoma. Int J Gynecol Pathol 25(2):121\u2013130","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"9446_CR49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/PGP.0b013e3181bbbcc1","volume":"29","author":"AD Tabrizi","year":"2010","unstructured":"Tabrizi AD, Kalloger SE, K\u00f6bel M, Cipollone J, Roskelley CD, Mehl E, Gilks CB (2010) Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases. Int J Gynecol Pathol 29(2):99\u2013107","journal-title":"Int J Gynecol Pathol"},{"issue":"9","key":"9446_CR50","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1158\/1541-7786.MCR-08-0466","volume":"7","author":"C Klausen","year":"2009","unstructured":"Klausen C, Leung PC, Auersperg N (2009) Cell motility and spreading are suppressed by HOXA4 in ovarian cancer cells: possible involvement of \u03b21 integrin. Mol Cancer Res 7(9):1425\u20131437","journal-title":"Mol Cancer Res"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-011-9446-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-011-9446-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-011-9446-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,26]],"date-time":"2021-12-26T11:33:29Z","timestamp":1640518409000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-011-9446-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,20]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["9446"],"URL":"https:\/\/doi.org\/10.1007\/s10585-011-9446-0","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,20]]}}}